Free Trial

agilon health (NYSE:AGL) Stock Price Up 7.4% - Still a Buy?

agilon health logo with Medical background

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) rose 7.4% during mid-day trading on Monday . The stock traded as high as $2.79 and last traded at $2.77. Approximately 654,664 shares changed hands during trading, a decline of 87% from the average daily volume of 4,907,535 shares. The stock had previously closed at $2.58.

Wall Street Analysts Forecast Growth

AGL has been the subject of several research reports. Benchmark reissued a "buy" rating and issued a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Evercore ISI reduced their price objective on agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft decreased their price objective on agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a report on Friday, August 9th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. Finally, Bank of America cut shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target for the company. in a research note on Wednesday, October 2nd. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $8.03.

Read Our Latest Stock Analysis on AGL

agilon health Stock Up 4.5 %

The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of -3.85 and a beta of 0.54. The firm has a fifty day moving average price of $3.58 and a 200 day moving average price of $5.13.

agilon health (NYSE:AGL - Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting analysts' consensus estimates of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the company earned ($0.04) earnings per share. agilon health's quarterly revenue was up 38.7% compared to the same quarter last year. As a group, sell-side analysts expect that agilon health, inc. will post -0.32 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Steven Sell purchased 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 3.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in AGL. J.Safra Asset Management Corp increased its holdings in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after acquiring an additional 3,625 shares in the last quarter. CWM LLC raised its position in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock worth $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC purchased a new stake in agilon health in the 2nd quarter valued at approximately $60,000. Bleakley Financial Group LLC purchased a new stake in agilon health in the 1st quarter valued at approximately $65,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock valued at $70,000 after buying an additional 10,674 shares during the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!
How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines